What is ToolGen Inc.'s contact information?

ToolGen Inc.'s contact information: info@toolgen.com, 02-3660-1300, +8228738168.

What industry does ToolGen Inc. belong to?

ToolGen Inc. is in the industry of: Research, Pharmaceuticals, Biotechnology, Agriculture.

What tech stack does ToolGen Inc. use?

Some of the popular technologies that ToolGen Inc. uses are: Cloudflare, Cdn.Js, Microsoft 365, Google Workspace, jQuery, Slick.

What are ToolGen Inc.'s office addresses?

ToolGen Inc. has 3 known office addresses: 8th Floor, 172 Magokjungang-ro, Gangseo-gu, Seoul, South Korea 서울시 강서구 마곡중앙로 172 제넥신 신사옥 8층 Seoul, 07789, KR #1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, Seoul, Korea, Republic Of.

What is ToolGen Inc.'s open headcount?

ToolGen Inc. has one job posting.

What is the number of ad campaigns for ToolGen Inc.?

ToolGen Inc. has no advertisements yet.

What is the number of recent news articles about ToolGen Inc.?

ToolGen Inc. has 4 news articles.

ToolGen Inc. - Pubrio Company Profile & Intent

ToolGen Inc.

South Korea · Research

Research

Pharmaceuticals

Biotechnology

Agriculture

Toolgen is committed to conducting research for revamping genome editing technology and thus developing not only therapeutics for humans but plants and animals of which the genetic characters are modified by the editing.

Company Insights

prnasia.com · partners_with · 2025-11-24

Open news

ToolGen and GenEditBio partner for genome editing therapeutics

ToolGen and GenEditBio form strategic cross-license agreement to develop in vivo genome-editing therapeutics, combining CRISPR-Cas9 and LNP delivery technologies.

Toolgen Inc.

Geneditbio Limited

prnasia.com · partners_with · 2025-11-24

Open news

GenEditBio and ToolGen partner for gene editing therapies

GenEditBio and ToolGen form strategic cross-licensing agreement to develop next-generation in vivo gene editing therapies, combining CRISPR-Cas9 and LNP delivery technologies.

Eli Lilly And Company

Toolgen Inc.

Thermo Fisher Scientific

Verve Therapeutics

Monsanto Nordeste Sa

Geneditbio Limited

prnasia.com · partners_with · 2025-11-24

Open news

GenEditBio and ToolGen partner for genome editing therapeutics

GenEditBio and ToolGen form strategic cross-license agreement to develop in vivo genome-editing therapeutics, combining CRISPR-Cas9 and LNP delivery technologies for 'once-and-done' treatments.

Toolgen Inc.

Geneditbio Limited

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 4 of 4

Frequently Asked Questions Regarding ToolGen Inc.

Company Overview

1999

Founded

Research

Industry

South Korea

Location

6,437,682

Ranking

31 employees

Size

Similar Companies

Get full access to view complete information